E-LIB Suche - Ergebnisse für: Dogu, Mehmet Hilmi

1

GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RE..:

DOGU, Mehmet Hilmi ; TEKGUNDUZ, Ali Irfan Emre ; DEVECI, Burak...
Mediterranean Journal of Hematology and Infectious Diseases. 15 (2023) 1 - p. e2023031 , 2023

Link: https://doi.org/10.4084/..

2

PB1897: GILTERITINIB IN TURKEY: EARLY ACCESS PROGRAM RESULT:

Dogu, Mehmet Hilmi ; Tekgunduz, Ali Irfan Emre ; Deveci, Burak...
HemaSphere. 7 (2023) S3 - p. e4210211 , 2023

Link: https://doi.org/10.1097/..

3

Real-Life Experience Regarding Clinical Characteristics and..:

Kayıkçı, Ömür ; Mehtap, Özgür ; Sarı, İsmail...
Turkish Journal of Hematology. 39 (2022) 3 - p. 170-177 , 2022

Link: https://doi.org/10.4274/..

4

The Real‐World Experience With Single Agent Ibrutinib in Re..:

Akpinar, Seval ; Dogu, Mehmet Hilmi ; Celik, Serhat...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 3 - p. 169-173 , 2022

Link: https://doi.org/10.1016/..

5

The Use of Hypomethylating Agents in Hematologic Malignanci..:

Serin, Istemi ; Dogu, Mehmet Hilmi
International Journal of Hematologic Oncology. 10 (2021) 4 - p. , 2021

Link: https://doi.org/10.2217/..

6

Clinical characteristics and therapeutic outcomes of paroxy..:

Goren Sahin, Deniz ; Akay, Olga Meltem ; Keklik, Muzaffer...
Annals of Hematology. 100 (2021) 7 - p. 1667-1675 , 2021

Link: https://doi.org/10.1007/..

7

Hemolytic anemia and plasma exchange:

Serin, Istemi ; Dogu, Mehmet Hilmi
Transfusion and Apheresis Science. 60 (2021) 5 - p. 103245 , 2021

Link: https://doi.org/10.1016/..

8

HL-007: Brentuximab Vedotin Consolidation Therapy after Aut..:

Ozbalak, Murat ; Akay, Olga Meltem ; Pehlivan, Mustafa...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S368-S369 , 2021

Link: https://doi.org/10.1016/..

9

Serum Aspergillus galactomannan lateral flow assay for the ..:

Serin, Istemi ; Dogu, Mehmet Hilmi
Mycoses. 64 (2021) 6 - p. 678-683 , 2021

Link: https://doi.org/10.1111/..

10

Brentuximab vedotin consolidation therapy after autologous ..:

Akay, Olga Meltem ; Ozbalak, Murat ; Pehlivan, Mustafa...
Hematological Oncology. 39 (2021) 4 - p. 498-505 , 2021

Link: https://doi.org/10.1002/..

11

Poster: HL-007: Brentuximab Vedotin Consolidation Therapy a..:

Ozbalak, Murat ; Akay, Olga Meltem ; Pehlivan, Mustafa...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S236 , 2021

Link: https://doi.org/10.1016/..

12

A Real-life Turkish Experience of Venetoclax Treatment in H..:

Gemici, Aliihsan ; Ozkalemkas, Fahir ; Dogu, Mehmet Hilmi...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) 8 - p. e686-e692 , 2021

Link: https://doi.org/10.1016/..

13

Convalescent plasma therapy in patients with COVID-19:

Altuntas, Fevzi ; Ata, Naim ; Yigenoglu, Tugce Nur...
Transfusion and Apheresis Science. 60 (2021) 1 - p. 102955 , 2021

Link: https://doi.org/10.1016/..

14

Patients with hematologic cancers are more vulnerable to CO..:

Başcı, Semih ; Ata, Naim ; Altuntaş, Fevzi...
Internal and Emergency Medicine. 17 (2021) 1 - p. 135-139 , 2021

Link: https://doi.org/10.1007/..

15

COVID-19 in hematopoietic cell transplant recipients:

On Behalf of Turkish Ministry of Health, Hematology Scientific Working Group ; Altuntas, Fevzi ; Ata, Naim...
Bone Marrow Transplantation. 56 (2020) 4 - p. 952-955 , 2020

Link: https://doi.org/10.1038/..